{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:58:28Z","timestamp":1773683908099,"version":"3.50.1"},"reference-count":97,"publisher":"Informa UK Limited","issue":"23","funder":[{"name":"NIH\/NCI"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.2217\/fon-2021-0262","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T08:46:52Z","timestamp":1621846012000},"page":"2989-3005","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Venetoclax-Based Combinations for the Treatment of Newly Diagnosed Acute Myeloid Leukemia"],"prefix":"10.1080","volume":"17","author":[{"given":"Tamer A","family":"Othman","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology & Oncology,University of California Davis School of Medicine,\rSacramento, CA95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tali","family":"Azenkot","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,University of California Davis School of Medicine,\rSacramento, CA95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin N","family":"Moskoff","sequence":"additional","affiliation":[{"name":"Pharmacy Department,University of California Davis School of Medicine,\rSacramento, CA95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew E","family":"Tenold","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology & Oncology,University of California Davis School of Medicine,\rSacramento, CA95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-5809","authenticated-orcid":false,"given":"Brian A","family":"Jonas","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology & Oncology,University of California Davis School of Medicine,\rSacramento, CA95817, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.195289"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.015974"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-730"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1406184"},{"issue":"12","key":"e_1_3_3_7_1","first-page":"1837","article-title":"Clinical presentation of acute myeloid leukaemia - a decade-long institutional follow-up","volume":"67","author":"Kulsoom B","year":"2017","unstructured":"Kulsoom B , ShamsiTS, AhmedN, HasnainSN. Clinical presentation of acute myeloid leukaemia - a decade-long institutional follow-up. J. Pak. Med. Assoc.67(12), 1837\u20131842 (2017).","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_3_3_9_1","unstructured":"National Cancer Institute . SEER cancer statistics review 1975\u20132016. (2018). based on November 2018 SEER data submission posted to the SEER website April 2019.https:\/\/seer.cancer.gov\/archive\/csr\/1975_2016\/results_merged\/topic_med_age.pdf"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.02.003"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904544"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12233"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj112"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1850255"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/jim-2018-000807"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2012971"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020004856"},{"key":"e_1_3_3_18_1","unstructured":"AbbVie Inc. US FDA. VENCLEXTA (venetoclax) package insert. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/208573s009lbl.pdf"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-801498"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.4600"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.208454"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0233-1"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.208587"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-138773"},{"key":"e_1_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-604520"},{"key":"e_1_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.813"},{"key":"e_1_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.8571"},{"key":"e_1_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-777722"},{"key":"e_1_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-733196"},{"key":"e_1_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328358f62d"},{"key":"e_1_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-551499"},{"key":"e_1_3_3_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3724"},{"key":"e_1_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.9429"},{"key":"e_1_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-621664"},{"key":"e_1_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22496"},{"key":"e_1_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-010-0048-8"},{"key":"e_1_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29428"},{"key":"e_1_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.606382"},{"key":"e_1_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0612-8"},{"key":"e_1_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-560557"},{"key":"e_1_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_175401"},{"key":"e_1_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1011"},{"key":"e_1_3_3_43_1","unstructured":"National Center for Biotechnology Information . PubChem compound summary for CID 49846579 venetoclax. (2021). https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Venetoclax"},{"key":"e_1_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2016.02.019"},{"key":"e_1_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00636"},{"key":"e_1_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-13-0609"},{"key":"e_1_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3048"},{"key":"e_1_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2012.12.013"},{"key":"e_1_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.3091.3091"},{"key":"e_1_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2006.10.006"},{"key":"e_1_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402434"},{"key":"e_1_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2013_085"},{"key":"e_1_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2017.01.003"},{"key":"e_1_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.741"},{"key":"e_1_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.071613"},{"key":"e_1_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30010-X"},{"key":"e_1_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2646"},{"key":"e_1_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0313"},{"key":"e_1_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.htct.2018.09.001"},{"key":"e_1_3_3_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-868752"},{"key":"e_1_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26039"},{"key":"e_1_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134736"},{"key":"e_1_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01600"},{"key":"e_1_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001267"},{"key":"e_1_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003988"},{"key":"e_1_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26117"},{"key":"e_1_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000243"},{"key":"e_1_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-127772"},{"key":"e_1_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134789"},{"key":"e_1_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134820"},{"key":"e_1_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139923"},{"key":"e_1_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25978"},{"key":"e_1_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019001239"},{"key":"e_1_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25369"},{"key":"e_1_3_3_75_1","unstructured":"National Comprehensive Cancer Network . Acute myeloid leukemia. (2021). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf"},{"key":"e_1_3_3_76_1","unstructured":"AbbVie Corporation . Product monograph including patient medication information. (2021). https:\/\/www.abbvie.ca\/content\/dam\/abbvie-dotcom\/ca\/en\/documents\/products\/VENCLEXTA_PM_EN.pdf"},{"key":"e_1_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134832"},{"key":"e_1_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134850"},{"key":"e_1_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-134300"},{"key":"e_1_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00572"},{"key":"e_1_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140646"},{"key":"e_1_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30210-6"},{"key":"e_1_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136120"},{"key":"e_1_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-141075"},{"key":"e_1_3_3_85_1","volume-title":"American Society of Hematology.","author":"Kadia Tm BG","year":"2020","unstructured":"Kadia Tm BG , PemmarajuN, DaverNet al. Phase II study of venetoclax added to cladribine+low dose AraC (LDAC) Alternating with 5-azacytidine demonstrates high rates of minimal residual disease (MRD) negative complete remissions (CR) and excellent tolerability in older patients with newly diagnosed acute myeloid leukemia (AML). Presented at: American Society of Hematology.CA, USA (2020)."},{"key":"e_1_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.TPS7567"},{"key":"e_1_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142074"},{"key":"e_1_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140729"},{"key":"e_1_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.7500"},{"key":"e_1_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-136968"},{"key":"e_1_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139752"},{"key":"e_1_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139884"},{"key":"e_1_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-139705"},{"key":"e_1_3_3_94_1","unstructured":"European Medicines Agency . Azacitidine Celgene. (2021). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/azacitidine-celgene"},{"key":"e_1_3_3_95_1","unstructured":"European Medicines Agency . EU\/3\/06\/370. (2021). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu306370"},{"key":"e_1_3_3_96_1","unstructured":"European Medicines Agency . EU\/3\/16\/1617. (2021). https:\/\/www.ema.europa.eu\/en\/medicines\/human\/orphan-designations\/eu3161617"},{"key":"e_1_3_3_97_1","unstructured":"Administration AGDOHTG . Australian public assessment report for venetoclax. (2020). https:\/\/www.tga.gov.au\/sites\/default\/files\/auspar-venetoclax-200924.docx"},{"key":"e_1_3_3_98_1","unstructured":"Agency PaMD . Summary of investigation results venetoclax posaconazole. (2020). https:\/\/www.pmda.go.jp\/files\/000237949.pdf"},{"key":"e_1_3_3_99_1","unstructured":"Nippon Shinyaku Co. Ltd . Vidaza\u00ae Approved For Treatment Of Myelodsyplastic Syndromes in Japan. (2011). https:\/\/www.nippon-shinyaku.co.jp\/english\/company_profile\/news.php?id=909"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-0262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:47:12Z","timestamp":1719125232000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-0262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":97,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.2217\/fon-2021-0262"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-0262","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-03-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}